Structural Fine-Tuning of Desmuramylpeptide NOD2 Agonists Defines Their In Vivo Adjuvant Activity.
Guzelj S, Nabergoj S, Gobec M, Pajk S, Klančič V, Slütter B, Frkanec R, Štimac A, Šket P, Plavec J, Mlinarič-Raščan I, Jakopin Ž.
Guzelj S, et al. Among authors: stimac a.
J Med Chem. 2021 Jun 10;64(11):7809-7838. doi: 10.1021/acs.jmedchem.1c00644. Epub 2021 May 27.
J Med Chem. 2021.
PMID: 34043358
Free PMC article.